Cargando…
Small Molecule Potentiator of Adjuvant Activity Enhancing Survival to Influenza Viral Challenge
As viruses continue to mutate the need for rapid high titer neutralizing antibody responses has been highlighted. To meet these emerging threats, agents that enhance vaccine adjuvant activity are needed that are safe with minimal local or systemic side effects. To respond to this demand, we sought s...
Autores principales: | Saito, Tetsuya, Sako, Yukiya, Sato-Kaneko, Fumi, Hosoya, Tadashi, Yao, Shiyin, Lao, Fitzgerald S., Shpigelman, Jonathan, Messer, Karen, Pu, Minya, Shukla, Nikunj M., Chan, Michael, Chu, Paul J., Cottam, Howard B., Hayashi, Tomoko, Carson, Dennis A., Corr, Maripat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505803/ https://www.ncbi.nlm.nih.gov/pubmed/34650551 http://dx.doi.org/10.3389/fimmu.2021.701445 |
Ejemplares similares
-
Small Molecule Calcium Channel Activator Potentiates
Adjuvant Activity
por: Saito, Tetsuya, et al.
Publicado: (2022) -
A Triple High Throughput Screening for Extracellular Vesicle Inducing Agents With Immunostimulatory Activity
por: Shukla, Nikunj M., et al.
Publicado: (2022) -
Discovery of a Novel Microtubule Targeting Agent as an Adjuvant for Cancer Immunotherapy
por: Sato-Kaneko, Fumi, et al.
Publicado: (2018) -
Generation and Application of a Reporter Cell Line for the Quantitative Screen of Extracellular Vesicle Release
por: Shpigelman, Jonathan, et al.
Publicado: (2021) -
A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal Reactogenicity
por: Sato-Kaneko, Fumi, et al.
Publicado: (2020)